N-(3,4-Dichloro-2-Fluorophenyl)-6-Methoxy-7-(((3aR,5R,6aS)-2-Methyloctahydrocyclopenta[c]Pyrrol-5-Yl)Methoxy)Quinazolin-4-Amine N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3aR,5r,6aS)-2-甲基八氢环戊戊二烯并[c]吡咯-5-基)甲氧基)喹唑啉-4-胺
CAS 781613-23-8 MFCD81613238
化学结构图
SMILES: COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCC1CC2CN(C)CC2C1
化学属性
| Mol. Weight | 491.3853 |
|---|---|
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name | N-(3,4-Dichloro-2-Fluorophenyl)-6-Methoxy-7-(((3aR,5R,6aS)-2-Methyloctahydrocyclopenta[c]Pyrrol-5-Yl)Methoxy)Quinazolin-4-Amine |
|---|---|
| Chemical Name Translation | N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3aR,5r,6aS)-2-甲基八氢环戊戊二烯并[c]吡咯-5-基)甲氧基)喹唑啉-4-胺 |
| PubChem Substance ID | 10458325 |
| InChI | InChI=1S/C39H38N4O5/c1-42-34(22-27-8-5-4-6-9-27)38(45)41-33(39(42)46)21-28-10-7-11-30(20-28)37(44)40-32-14-12-26(13-15-32)16-18-43-19-17-29-23-35(47-2)36(48-3)24-31(29)25-43/h4-15,20-24H,16-19,25H2,1-3H3,(H,40,44)(H,41,45)/b33-21-,34-22- |
| Synonym | EXEL-7647 N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta(c)pyrrol-5-yl)methoxy)-4-quinazolinamine XL-647 XL-647; XL 647; XL647; EXEL7647; EXEL-7647; EXEL7647; KD-019; KD019; KD 019. XL647 tesevatinib |
| Formula | C24H25Cl2FN4O2 |
| IUPAC Name | N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine. |
| InChIKey | RTIZZWMBGKGLFO-YWQXDYITSA-N |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- Tesevatinib, also known as XL647, EXEL-7647 and KD-019, is a n orally bioavailable small-molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. XL647 binds to and inhibits several tyrosine receptor kinases that play major roles in tumor cell proliferation and tumor vascularization, including epidermal growth factor receptor (EGFR; ERBB1), epidermal growth factor receptor 2 (HER2; ERBB2), vascular endothelial growth factor receptor (VEGFR), and ephrin B4 (EphB4). This may result in the inhibition of tumor growth and angiogenesis, and tumor regression.
